About Simplify Medical, Creator of
Simplify® Cervical Artificial Disc

Company Top Disc

Our story is simple.
Make the modern cervical disc replacement.

Simplify Medical looked at how we could improve upon existing devices to provide patients and surgeons the best cervical disc replacement available. Our lower disc heights, MRI imaging capabilities, physiologic motion, biologic materials, and straightforward procedure set us apart from other discs on the market.

Simplify Medical IP Portfolio

Meet the Simplify Medical Team

David Hovda

President & Chief Executive Officer

Mr. Hovda has over 25 years of experience in the medical device industry. Prior to Simplify Medical and SpinalMotion, Simplify Medical’s predecessor company, he served as Vice President and Managing Director of the Spine and ENT divisions of ArthroCare, where he was responsible for the commercialization of numerous products and two business units. He also worked at Medtronic in corporate development and the corporate ventures group, which created the Inspire® sleep apnea treatment system. Mr. Hovda is a member of the Board of Directors for Pro-Dex, Inc. (PDEX, Nasdaq), a manufacturer of powered surgical instrumentation, where he is the Chairman of the Audit Committee. Mr. Hovda served as a Lieutenant in the United States Navy and completed two tours of duty. He received an MBA from Harvard Graduate School of Business Administration and a BS in Civil Engineering from Northwestern University. He is an inventor on over fifty medical device patents.

Cindy Lynch, JD, MBA

Vice President, General Counsel

Ms. Lynch has been providing strategic legal and intellectual property advice to startup medical device companies for over 15 years. Prior to joining Simplify Medical, she served as Vice President, Intellectual Property at Conor Medsystems, Moximed, SpinalMotion, and Elixir Medical. Ms. Lynch was also a partner at one of the oldest and largest patent law firms in the U.S. and a Patent Examiner at the U.S. Patent and Trademark Office. She received her JD from George Mason University, her MBA from San Francisco State University, and a BS in Mechanical Engineering from Tufts University.

Beth Neil

Vice President, Clinical Affairs

Ms. Neil has over 20 years of experience in the medical device industry, specializing in clinical research. Prior to joining Simplify Medical as the Vice President of Clinical Affairs, she held positions with Link Spine Group and Healthtronics Surgical Services, as well as various contract research organizations. Ms. Neil holds an MS degree in Physical Therapy from Duke University.

Mark Alvis, DVM

Vice President, Quality Assurance & Operations

Dr. Alvis has over 20 years of experience in the preclinical assessment of medical devices and pharmaceutical agents. Prior to joining Simplify Medical, he served as General Manager of Angiotech Biomaterials, where he was responsible for all business activities at their Palo Alto, CA facility. He also worked at NeuColl Inc. in the capacity of Vice President of Research and Development. Dr. Alvis holds a Doctor of Veterinary Medicine degree from Colorado State University.

Brian Polonet

Vice President, Sales & Marketing

Mr. Polonet has worked in the medical device industry for 29 years, with the last 19 years in spine. Prior to joining Simplify Medical, he was a managing partner in TDR Associates, a consulting company which managed the one and two-level study enrollment for Simplify Medical. He has also held positions of Vice President of Sales and Marketing at Paradigm Surgical, LLC and Vice President of Sales at SpinalMotion. He has had a leadership role in four IDE studies for artificial discs. Mr. Polonet holds a BA in Business Administration from Austin College.

Kim Norton

Vice President, Reimbursement

Ms. Norton has worked in the fields of reimbursement, outcomes research, and government relations for over 25 years. She has deep experience with artificial disc technologies, having led the reimbursement efforts at several companies, including as Head of Reimbursement and Payer Relations for Aesculap, Inc. and Vice President of Reimbursement for both LDR Spine and DePuy Synthes. Kim earned a master’s degree in public policy from the University of California at Berkeley.

Bryan Barr

Senior Director, Operations

Mr. Barr has over 30 years of experience in quality assurance, operations, and research and development. Prior to joining Simplify Medical, he served in a variety of management positions for ArthroCare, Parallax Medical, and Norian. Mr. Barr also served as a materials scientist for Parallax Medical and Norian. He holds 17 patents and received his MS in Materials Science and Engineering from UCLA.

Yves Arramon, PhD

Senior Director, Research & Development

Dr. Arramon has over 20 years of experience designing spinal implants, vertebral compression fracture systems, and minimally invasive devices. He is a published author in the field of bone mechanics and bone remodeling. Prior to joining Simplify Medical, he served as Director, R&D Spinal Motion, Director of Product Development at Calcitec, Senior R&D Engineer at ArthroCare, and R&D engineer at Parallax Medical. Dr. Arramon holds a PhD in Mechanical Engineering from the City University of New York and has 20 issued U.S. patents in his name.

Our Investors


M. H. Carnegie & Co.

M.H. Carnegie & Co. is a venture capital, private equity, and alternative asset manager based in Sydney, Australia. Its funds manage direct investments on behalf of institutions, and wholesale and high net worth investors, with $350 million in committed capital across several funds.

Visit Website Click



LSP is one of Europe’s largest and most experienced healthcare investment firms with over 25 years of nurturing and growing healthcare investment opportunities with the potential to have a positive impact on society. LSP has offices in Amsterdam, Munich, and Boston.

Visit Website Click


Sectoral Asset Management

Sectoral Asset Management is a healthcare specialist managing public and private equity portfolios. Sectoral has one of the world’s longest track records in managing biotech equities and is a sub-advisor of numerous healthcare and biotech funds offered by partners in Europe, North America, and Asia.

Visit Website Click


Simplify Medical is an independent company whose Simplify Cervical Artificial Disc, is currently FDA-approved for 1-level use. The late stage 2-level indication is not yet approved and is for investigational use only. Please stay tuned for updates. We’d love to hear from you.

News and Events

Press Releases

Simplify Medical Announces First Implantation of its Cervical Artificial Disc in the U.S. Following 1-Level Approval from the FDA

Sunnyvale, CA – December 16, 2020 – Simplify Medical, Inc., a privately-held company focused on cervical spinal disc arthroplasty and developer of the Simplify® Cervical Artificial Disc, today announced its first surgery following the recent FDA approval for 1-level use. The Simplify Disc is designed for MRI compatibility*, physiologic motion, and anatomical height-matching, with ...

Read More right arrow


2020 Canaccord Genuity Medical Technologies & Diagnostics Forum

Title: Simplify Medical Company Presentation

When: 11:00 AM Eastern Time

Where: www.canaccordgenuity.com/capital-markets/about-us/events

Who: David Hovda, Simplify Medical President & CEO

Read More right arrow


DOCS Spine & Orthopedics 2nd Annual Hybrid Arthroplasty Summit 2020

When: 5:00 PM Pacific Time

Where: www.docsspineortho.com/total-disc-arthroplasty-conference/

Who: Scott Blumenthal, MD, Orthopedic Spine Surgeon

Read More right arrow


2020 Musculoskeletal New Ventures Conference (MNVC)

When: 11:30 AM - 1:30 PM Eastern Time

Where: www.mnvc.org

Who: David Hovda, Simplify Medical President & CEO, and Brian Polonet, VP of Simplify Medical Sales & Marketing

Read More right arrow

Press Releases

Simplify Medical Completes PMA Submission for 2-Level Simplify Disc IDE Study

Builds on recent 1-Level PMA Approval

SUNNYVALE, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Simplify Medical, Inc., maker of the Simplify® Cervical Artificial Disc, announced today the completion of the Pre-Market Approval (PMA) submission for the 2-level Simplify Disc IDE Study to the U.S. Food and Drug Administration (FDA). The Simplify Disc is designed for MRI compatibility, physiologic ...

Read More right arrow


Simplify Disc 2-Level Cervical Disc Replacement Prospective Outcome Data from FDA IDE Trial Presented at NASS 2020

162. 2-level Cervical Disc Replacement Using a PEEK-on-Ceramic Device: Prospective Outcome Data from an FDA IDE Trial

Domagoj Coric, MD1; Richard D. Guyer, MD2; Pierce D. Nunley, MD3; K. Brandon Strenge, MD4; Donna D. Ohnmeiss, PhD5

1Carolina Neurosurgery & Spine Associates, Charlotte, NC, US; 2Center for Disc Replacement at Texas Back Institute, Plano, TX, US; 3Spine Institute of ...

Read More right arrow


See the Difference Today